₹ 3.4 Cr
Volume Transacted
(Nov 21, 2024)
5.7 K
Stocks Traded
(Nov 21, 2024)
Last Updated on: Nov 22, 2024
Divis Laboratories Ltd
BSE
21 Nov, 2024
5975.779.6 (1.3%)
Prev Close
5896.15
Open Price
5944.95
Bid Price (QTY)
Offer Price (QTY)
Volume
5731
Today's High / Low
6002.6 / 5884.5
52 WK High / Low
6276.2 / 3350.1
NSE
21 Nov, 2024
5977.176.3 (1.3%)
Prev Close
5900.85
Open Price
5880.1
Bid Price (QTY)
Offer Price (QTY)
Volume
427565
Today's High / Low
6004.5 / 5880.1
52 WK High / Low
6275.9 / 3350.0
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
21 Nov 2024 | 5975.7 | 5944.95 | 6002.6 | 5884.55 |
19 Nov 2024 | 5896.15 | 5760.05 | 5955 | 5760.05 |
18 Nov 2024 | 5762.85 | 5660.2 | 5811.4 | 5660.2 |
14 Nov 2024 | 5744.35 | 5712.55 | 5816.35 | 5712.55 |
13 Nov 2024 | 5773.1 | 5720.2 | 5828.65 | 5717.1 |
12 Nov 2024 | 5806.9 | 5850 | 5943.95 | 5779.8 |
11 Nov 2024 | 5893.8 | 6112.05 | 6145.6 | 5790 |
08 Nov 2024 | 5938.15 | 5989.95 | 6061.7 | 5872.9 |
07 Nov 2024 | 5958.5 | 6005.5 | 6030.2 | 5882.85 |
06 Nov 2024 | 5939.7 | 5795.35 | 6005.5 | 5795.35 |
Date | Price (₹) |
---|---|
21 Nov 2024 | 5975.7 |
19 Nov 2024 | 5896.15 |
18 Nov 2024 | 5762.85 |
14 Nov 2024 | 5744.35 |
13 Nov 2024 | 5773.1 |
12 Nov 2024 | 5806.9 |
11 Nov 2024 | 5893.8 |
08 Nov 2024 | 5938.15 |
07 Nov 2024 | 5958.5 |
06 Nov 2024 | 5939.7 |
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
---|
Cipla Ltd | -2.3 | -3.8 | -8.1 | 1.6 | 16.9 | 63.8 | 201.9 | 133.7 |
Dr Reddys Laboratories Ltd | -2.6 | -10.8 | -15.4 | 3.3 | 5.8 | 29.7 | 107.4 | 69.2 |
Torrent Pharmaceuticals Ltd | 0.1 | -8.5 | -7.3 | 15.7 | 46.5 | 125.4 | 257.1 | 520.1 |
Sun Pharmaceuticals Industries Ltd | 0.5 | -6.3 | 0.8 | 15.3 | 47.9 | 130.7 | 297.5 | 111.0 |
Divis Laboratories Ltd | 4.0 | 0.9 | 22.0 | 48.7 | 60.6 | 27.7 | 242.4 | 588.2 |
Mankind Pharma Ltd | -2.0 | -3.3 | 11.9 | 22.4 | 31.3 | 0.0 | 0.0 | 0.0 |
Entity | 1W |
---|---|
Cipla Ltd | -2.3 |
Dr Reddys Laboratories Ltd | -2.6 |
Torrent Pharmaceuticals Ltd | 0.1 |
Sun Pharmaceuticals Industries Ltd | 0.5 |
Divis Laboratories Ltd | 4.0 |
Mankind Pharma Ltd | -2.0 |
Last updated time: 22 Nov 9.00 AM
Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Sales | 4106 | 3913 | 4946 | 5394 | 6969 | 8960 | 7767 | 7845 |
Sales YoY Gr. | - | -4.7% | 26.4% | 9.1% | 29.2% | 28.6% | -13.3% | 1.0% |
Adj EPS | 39.95 | 33.04 | 50.96 | 51.86 | 74.75 | 111.53 | 68.83 | 60.38 |
YoY Gr. | - | -17.3% | 54.2% | 1.8% | 44.1% | 49.2% | -38.3% | -12.3% |
Adj Net Profit | 1060 | 877 | 1353 | 1377 | 1984 | 2960 | 1824 | 1600 |
BVPS | 201.82 | 223.2 | 262.09 | 275.38 | 350.15 | 441.82 | 481.77 | 512.11 |
Parameter | 2017 |
---|---|
Sales | 4106 |
Sales YoY Gr. | - |
Adj EPS | 39.95 |
YoY Gr. | - |
Adj Net Profit | 1060 |
BVPS | 201.82 |
Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Return on Capital Emp. % | 33 | 35.49 | 28.67 | 21.62 | 28.44 | 25.29 | 31.97 | 34.96 | 19.31 | 16.41 |
Op. Profit Mgn % | 38.54 | 39.84 | 37.07 | 35.17 | 41.01 | 37.31 | 41.95 | 44.61 | 34.94 | 32.44 |
Net Profit Mgn % | 27.1 | 29.59 | 25.82 | 22.41 | 27.35 | 25.52 | 28.47 | 33.04 | 23.48 | 20.4 |
Debt to Equity % | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
Parameter | 2015 |
---|---|
Return on Capital Emp. % | 33 |
Op. Profit Mgn % | 38.54 |
Net Profit Mgn % | 27.1 |
Debt to Equity % | 0.01 |
No data available
No data available
Unlimited trading at just
Rs. 199*